Long-term Safety and Tolerability of Ambrisentan Treatment for Pediatric Patients with Pulmonary Arterial Hypertension: an Open-Label Extension Study.
EUROPEAN JOURNAL OF PEDIATRICS（2024）
Key words
Ambrisentan,Endothelin receptor antagonist,Open-label extension,Pediatric PAH
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined